Harbin Gloria Pharmaceuticals Co., Ltd.

Industry

  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
    • Nutraceuticals

Other Names/Subsidiaries

  • Guangzhou Gloria Biosciences Co., Ltd.
  • Yu Heng Pharmaceutical
  • Shanghai Huatuo
  • Ono (china)
  • Harbin Dandelion Pharmaceutical Co., Ltd.,
  • Harbin Yuheng Jingwei Pharmaceutical Development Co., Ltd.
  • Pude Pharmaceutical, Beijing Podconley Pharmaceutical Technology & Development Co., Ltd.
See more in Biomedtracker

Latest on Harbin Gloria Pharmaceuticals Co., Ltd.

Scrip

GloriaBio's Zimberelimab Experience Indicative Of China Commercial IO Challenges

 
• By Dexter Jie Yan

Gloria Biosciences (GloriaBio), a small-sized Chinese developer of PD-1/L1 checkpoint inhibitors, has emerged as the first domestic company of 10 in the country's immuno-oncology sector to concede com

Scrip

Younger Females' Cancer Incidence Increases Significantly In China

 
• By Brian Yang

The latest paper published by a research team at the National Cancer Center of China serves as a timely reminder that cancer, rather than COVID-19, remains the top public health concern in the country

Scrip

Pfizer, CStone Score China's Seventh Immuno-Oncology Approval

 
• By Brian Yang

CStone Pharmaceuticals Co. Ltd. has become the latest oncology developer to score an anti- PD-L1 antibody win in China. The Shanghai-based company obtained on 21 December the green light to market Ce

HBW Insight

GNC, Vitamin Shoppe Not On Same Page In Solving Similar Growth Challenges

 
• By Malcolm Spicer

[GNC Holdings Inc.] and [Vitamin Shoppe Inc.] have in common the challenges of implementing solutions to increase sales following extended growth slumps. The two leading US nutritional, health and wel